Skip to main content

RX Updates

The Impact of Obesity on Psoriatic Arthritis

Sponsored by Lilly Medical Affairs
Obesity is common in PsA and may worsen disease activity and reduce treatment effectiveness through shared inflammatory pathways. Weight intervention may improve outcomes and support achievement of targets of disease control.

Advancing the Treatment Landscape for Pediatric Psoriatic Disease

Sponsored by Johnson & Johnson
Learn more about a treatment offering pediatric patients 6 years and older who also weigh at least 40 kg, and their physicians and adult caregivers, an option that may improve skin clearance for moderate to severe plaque psoriasis or treat active psoriatic arthritis, collectively known as psoriatic disease.

Underserved and Under-treated

RheumNow
Watch our Underserved and Under-Treated series as part of this month's Mission: APP Partners in Care campaign. Now available: Pain Management and Workforce & APPs

IL-23 Inhibition Across Psoriatic Disease* and Inflammatory Bowel Disease†

Sponsored by Johnson & Johnson
Watch Dr. Khattri & Jennifer Labas, MSN, discuss IL-23 inhibition in adults with active PsA, moderate to severe plaque PsO, moderately to severely active UC, & moderately to severely active CD

Sjögren’s Disease – What Are You Missing?

Sponsored by Novartis Pharmaceuticals Corporation
What could you be missing in Sjögren's disease? Explore hypothetical patient cases with atypical presentations, systemic manifestations, and overlooked symptoms. Gain expert insights and practical tips for clinical assessment from Dr Shereen Mahmood and learn how the ESSDAI can help you measure disease activity.

A JAKi in GCA: Phase 3 Results Through 2 Years

Sponsored by AbbVie Medical Affairs + Health Impact
Listen as rheumatologists Dr. Anisha Dua and Dr. Ben Boone discuss the latest efficacy and safety results over 2 years from a Phase 3 trial in GCA, including remission, flares, and glucocorticoid use in patients continuing vs withdrawing a JAKi"

A JAKi CHAT: Shared Decision-Making in RA

Sponsored by AbbVie Medical Affairs + Health Impact
Experts Dr. Jeffrey Curtis and Dr. Kevin Winthrop discuss best practices for shared decision-making, how to talk with patients about the risks of poorly controlled RA, and ways to use a new tool for visualizing the long-term safety of a JAKi.

ILD Treatment and Guidelines

Watch our 11-video series on ILD Treatment and Guidelines including videos on assessing ILD, guidelines caveats and concerns, and more.

Structural damage progression in active PsA

Sponsored by Johnson & Johnson
Watch Dr. Philip Mease discuss the impact of structural damage on active PsA and follow along as he reviews clinical trial data

Navigating the Path to SLE Remission

Sponsored by AstraZeneca Medical Affairs
Watch rheumatologists Dr Anca Askanase and Dr Cristina Arriens discuss their clinical perspectives on how to target and achieve DORIS remission in clinical practice.

GCA: Case by Case

Sponsored by Novartis US Medical Affairs
Dive into 4 hypothetical case studies that reveal the diverse and often complex presentations of giant cell arteritis (GCA). Each case is guided by expert commentary from Dr Michael Putman, where he offers practical insights and clinical pearls to enhance your therapeutic strategies for this multifaceted condition.

Debunked. Expert perspectives on Sjögren’s Disease myths

Sponsored by Novartis Medical Affairs
How well do you know Sjögren’s disease? Test your knowledge and then hear rheumatologist, Dr Sara McCoy, discuss common myths and realities about managing patients with Sjögren’s disease.
×